Journal Publications

Patton WN, Nivison-Smith I, Bardy P, Dodds A, Ma DDF, Shaw PJ, Kwan J, Wilcox L, Butler A, Carter JM, Blacklock H, Szer J. Graft transit time has no effect on outcome of unrelated donor haematopoietic cell transplants performed in Australia and New Zealand: a study from the Australasian Bone Marrow Transplant Recipient Registry. Biol Blood and Marrow Transplant. 2017; 23:147-152.

Nelson AS, Vajdic CM, Ashton LJ, Le Marsney RE, Nivison-Smith I, Wilcox L, Dodds AJ, O'Brien TA. Incident cancers and late mortality in Australian children treated by allogeneic stem cell transplantation for non-malignant diseases. Pediatr Blood Cancer 2017; 64:197-202.

Kruger P, Cooney J, Nivison-Smith I, Bardy P, Ma D, Szer J, Durrant S. All is not lost in accelerated phase/blast crisis and after tyrosine kinase inhibitors fail in chronic myeloid leukaemia: a retrospective study of allogeneic stem cell transplant outcomes in Australia and New Zealand. Bone Marrow Transplant. 2016;51:1400-1403.

Nath CE, Trotman J, Tiley C, Presgrave P, Joshua D, Kerridge I, Kwan YL, Gurney H. McLachlan AJ, Earl JW, Nivison-Smith I, Zeng L, Shaw PJ. High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation. Br J Clin Pharmacol. 2016; in press

Vajdic CM, Mayson E, Dodds AJ, O'Brien TA, Wilcox L, Nivison-Smith I, Le Marsney R, Daniels B, Ashton LJ, CAST study investigators. Second cancer risk and late mortality in adult Australians receiving allogeneic haematopoietic stem cell transplantation: A population-based cohort study. Biol Blood Marrow Transplant. 2016;22:949-956.

Nivison-Smith I, Bardy P, Dodds AJ, Ma DD, Aarons D, Tran S, Wilcox L, Szer J. A Review of Hematopoietic Cell Transplantation in Australia and New Zealand, 2005 to 2013. Biol Blood Marrow Transplant. 2016;22:284-291.

Nelson AS, Ashton LJ, Vajdic CM, Le Marsney RE, Daniels B, Nivison-Smith I, Wilcox L, Dodds AJ, O'Brien TA. Second cancers and late mortality in Australian children treated by allogeneic HSCT for hematological malignancy. Leukemia 2014;29:441-447.

Ashton LJ, Le Marsney RE, Dodds AJ, Nivison-Smith I, Wilcox L, O'Brien TA, Vajdic CM. A population-based cohort study of late mortality in adult autologous hematopoietic stem cell transplant recipients in Australia. Biol Blood Marrow Transplant 2014;20:937-945.

Bilmon I, Nivison-Smith I, Hertzberg M, Ritchie D, Greenwood M, Spencer A, Kennedy G, Bryant A, Moore J. Outcomes following second allogeneic haematopoietic transplants using fludarabine-melphalan conditioning. Bone Marrow Transplant 2014;49:852-853. (Letter)

Bilmon IA, Ashton LJ, Le Marsney RE, Dodds AJ, O'Brien TA, Wilcox L, Nivison-Smith I, Daniels B, Vajdic CM and CAST study group. Second cancer risk in adults receiving autologous haematopoietic SCT for cancer: a population-based cohort study. Bone Marrow Transplant 2014;49:691-698.

Bryant A, Nivison-Smith I, Pillai ES, Kennedy G, Kalff A, Ritchie D, George B, Hertzberg M, Patil S, Spencer A, Fay K, Cannell P, Berkahn L, Doocey R, Spearing R, Moore J. Fludarabine Melphalan reduced intensity conditioning allotransplantation provides similar disease control in lymphoid and myeloid malignancies - analysis of 344 patients. Bone Marrow Transplant 2014; 49:17-23.

Gordon SJ, Nivison-Smith I, Szer J, Chapman JR. Volunteer unrelated donor experience after administration of filgrastim and apheresis for the collection of haemopoietic stem cells - the Australian perspective. Intern Med J 2013;43(11):1183-1190.

Mitchell R, Nivison-Smith I, Anazodo A, Tiedemann K, Shaw P, Teague L, Fraser C, Carter T, Tapp H, Alvaro F, O'Brien T. Outcomes of hematopoietic stem cell transplantation for inherited metabolic disorders: a report from Australian and New Zealand Children's Haematology/Oncology Group (ANZCHOG) and the Australasian Bone Marrow Transplant Recipient Registry (ABMTRR). Pediatr Transplant 2013;17(6):582-588.

Nivison-Smith I, Simpson JM, Dodds AJ, Ma DDF, Szer J, Bradstock KF. A population-based analysis of the effect of autologous hematopoietic cell transplantation in the treatment of multiple myeloma.Leuk Lymphoma 2013;54(8):1671-1676.

Mitchell R, Nivison-Smith I, Anazodo A, Tiedemann K, Shaw P, Teague L, Fraser C, Carter T, Tapp H, Alvaro F, O'Brien T. Hematopoietic stem cell transplantation outcomes in primary immunodeficiency: a report from the Australian and New Zealand Children's Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry. Biol Blood Marrow Transplant 2013;19(3):338-343.

Nivison-Smith I, Dodds AJ, Butler J, Bradstock KF, Ma DDF, Simpson JM, Szer J. Allogeneic hematopoietic cell transplantation for myelofibrosis in Australia and New Zealand: older recipients receiving myeloablative conditioning at increased mortality risk. Biol Blood Marrow Transplant 2012; 18:302-308.

Nivison-Smith I, Dodds AJ, Doocey R, Ganly P, Gibson J, Ma DDF, Simpson JM, Szer J, Bradstock KF. Allogeneic hematopoietic cell transplantation for multiple myeloma using reduced intensity conditioning therapy, 1998-2006: factors associated with improved survival outcome. Leuk Lymphoma 2011; 52: 1727-1735.

Nivison-Smith I, Dodds AJ, Dunckley H, Ma DDF, Moore JJ, Simpson JM, Szer J, Bradstock KF. Increased activity and improved outcome in unrelated donor haemopoietic cell transplants for acute myeloid leukaemia in Australia, 1992-2005. Internal Medicine Journal 2011; 41: 27-34.

Nivison-Smith I, Simpson JM, Dodds AJ, Ma DDF, Szer J, Bradstock KF. Relative survival of long-term hematopoietic cell transplant recipients approaches general population rates. Biol Blood Marrow Transplant 2009; 15: 1323 - 1330.

Worthley DL, Ruszkiewicz A, Davies R, Moore S, Nivison-Smith I, To LB, Browett P, Western R, Durrant S, So J, Young GP, Mullighan CG, Bardy PG, Michael MZ. Human gastrointestinal neoplasia-associated myofibroblasts can develop from bone marrow-derived cells following allogeneic stem cell transplantation. Stem Cells 2009; 27:1463-1468.

Moore AS, Shaw PJ, Hallahan AR, Carter TL, Kilo T, Nivison-Smith I, O’Brien TA, Tapp H, Teague L, Wilson SR and Tiedemann K. Haemopoietic stem cell transplantation for children in Australia and New Zealand, 1998-2006: a report on behalf of the Australasian Bone Marrow Transplant Recipient Registry and the Australian and New Zealand Children’s Haematology Oncology Group. Med J Aust 2009; 190: 121-125.

Feyler S, Prince HM, Pearce R, Towlson K, Nivison-Smith I, Schey S, Gibson J, Patton N, Bradstock K, Marks DI and G Cook on behalf of the BSBMT & ABMTRR. The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study. Bone Marrow Transplant 2007; 40: 443 - 450.

Nivison-Smith I, Bradstock KF, Dodds AJ, Hawkins PA, Ma DDF, Moore JJ, Simpson JM, Szer J. Hematopoietic stem cell transplantation in Australia and New Zealand, 1992-2004. Biol Blood Marrow Transplant 2007; 13: 905 - 912.

Moore J, Nivison-Smith I, Goh K, Ma D, Bradstock K, Szer J, Durrant S, Schwarer A, Bardy P, Herrmann R, Dodds A. Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia. Biol Blood Marrow Transplant 2007; 13: 601-607.

Nivison-Smith I, Bradstock KF, Dodds AJ, Hawkins PA, Szer J. Haemopoietic stem cell transplantation in Australia and New Zealand, 1992-2001: A progress report from the Australasian Bone Marrow Transplant Recipient Registry. Intern Med J 2005; 35: 18-27.

Nivison-Smith I, Bradstock KF, Szer J, Durrant S, Dodds A, Herrmann R, Schwarer AP, Gibson J, To LB, Arthur C. Allogeneic haemopoietic cell transplants in Australia, 1996 - a multi-centre retrospective comparison of the use of peripheral blood stem cells with bone marrow. Bone Marrow Transplant 2001; 28:21-27.

Atkinson K, Nivison-Smith I, Hawkins T. Haemopoietic cell transplantation in Australia 1992-95: a report from the Australian Bone Marrow Transplant Recipient Registry. Aust NZ J Med 1997; 27: 408-419.

Atkinson K, Downs K, Hawkins T. Bone marrow transplantation in Australia during 1992. Australian Bone Marrow Transplant Recipient Data Registry. Bone Marrow Transplant 1994; 13:737-739.

UpdateThank you for your support at HAA 2017, we hope to see you at Blood 2018 in Brisbane